Transparency Market Research
Circulating Tumor Cells (CTCs) Prognostic Technologies Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 – 2020
Published Date 26-June-2014
100 Page Report
Buy Now
Request Sample
Press Release Circulating Tumor Cells (CTCs) Prognostic Technologies Market in 2020: Transparency Market Research
Transparency Market Research State Tower, 90, State Street, Suite 700. Albany, NY 12207 United States www.transparencymarketresearch.com sales@transparencymarketresearch.com
REPORT DESCRIPTION
Circulating Tumor Cells (CTCs) Prognostic Technologies Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 – 2020 This report provides the market analysis for various technologies and applications used for the enrichment and detection of circulating tumor cells (CTCs). The stakeholders of this report include companies and research institutes involved in the production of prognosis kits and research and development activities related to circulating tumor cells technologies as well as the new entrants who wish to enter this market. The market overview section of the report analyzes the market dynamics and trends such as drivers, restraints and opportunities that would affect the current and future scenario of the CTC technologies market. Porter’s five forces analysis is included in this study to provide thorough analysis about the competitive status, and market attractiveness analysis has been added to describe the market outlook in different geographies. Event impact analysis is provided in this report for a brief understanding of the technological advancements that have taken place in the past and are planned for the future. Value chain analysis of the market is discussed to recognize value-creating activities from a number of processes, which can provide CTC technology a competitive advantage over other technologies. Browse Circulating Tumor Cells (CTCs) Prognostic Technologies Market Research Report with complete TOC at http://www.transparencymarketresearch.com/ctcs-prognostic-technologiesmarket.html Circulating tumor cells (CTCs) are specialized rare cells detached from primary tumors and disseminated in the vasculature system of the body, eventually causing metastasis. CTCs are composed of cells that act as seeds for successive development of additional metastatic tumors in essential distant organs, which is a cause of majority of cancer-related deaths. These CTCs are not easily detected, as these are present in less numbers in the blood stream. Tumors shed nearly 1 million circulating tumor cells (CTCs) per gram of tumor tissue. The global circulating tumor cells (CTCs) prognostic technologies market is segmented based on technologies and applications. Moreover, the technology market is further segmented into tumor cell enrichment and tumor cell detection. Get Free Sample Report at http://www.transparencymarketresearch.com/sample/sample.php? flag=S&rep_id=2497 Based on tumor cell enrichment technologies, the report includes market analysis of filtration, centrifugation and immunological & immunomagnetic enrichment methods. Based on tumor cell detection technologies, the market is segmented into molecular methods and optical methods. Furthermore, based on the applications, the CTC prognostic technologies market is segmented into breast cancer, colorectal cancer, prostate cancer and others (lung, ovarian and pancreatic cancer). Market forecast for all these segments has been provided in the report for the period 2012 to 2020 in terms of USD million, along with CAGR for the forecast period 2014 to 2020, considering 2013 as the base year.
Browse More Medical Devices Related Research Reports at http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html Geographically, the global CTCs prognostic technologies market has been segmented into four major regions: North America, Europe, Asia Pacific and Rest of the World (RoW). North America is the leading market for CTCs prognostic technologies owing to the high adoption rate for advanced prognostic technologies as well as high prevalence and incidence rate of cancer. However, low commercial availability of these technologies and stringent regulatory approvals of these technologies are some of the factors that have led to the sluggish growth of this market. However, other regions such as Asia-Pacific is also expected to show a substantial growth rate owing to the increasing base of cancer patients coupled with high government support and growing adoption rate for advanced therapeutic monitoring technologies. The market revenue of CTC technologies for 2012 and 2020 and forecast from 2014 to 2020 in respective regions in terms of USD million and value percentage, respectively, is explained in this section of the report. The report concludes with the profiles of key players in the CTC technologies market. Major companies profiled in this report include AdnaGen AG, Advanced Cell Diagnostics, Inc., AVIVA BioSciences Corporation, Celula, Inc., Epic Sciences, Inc., Fluxion Biosciences, Inc., Rarecells USA, Inc., Silicon Biosystems, S.p.A., Veridex, LLC, Vitatex, Inc. and others.
TABLE OF CONTENT Chapter 1 Introduction 1.1 Report Description 1.2 Market Segmentation 1.3 Research Methodology
Chapter 2 Executive Summary 2.1 Market Snapshot: Global CTCs Prognostic Technologies Market 2.2 Comparative Analysis: Global CTCs Prognostic Technologies Market, by Geography, 2013 & 2020 (Value %)
Chapter 3 Global CTCs Prognostic Technologies Market Overview 3.1 Market Dynamics and Overview 3.1 Market Drivers 3.1.1 Escalating Prevalence Rate of Cancer
3.1.2 High Cost-benefit Ratio 3.1.3 Increased Evaluation of Therapeutic Monitoring 3.1.4 Technological Development 3.2 Market Restraints 3.2.1 High Pricing Associated with CTCs Detection 3.2.2 Lack of Specificity and Sensitivity 3.2.3 Reluctance in Adopting Advanced Prognostic Technologies 3.3 Market Opportunities 3.3.1 Strengthening Distribution Network In Emerging Markets 3.3.2 Development of Personalized Medicines based on CTCs
Browse Circulating Tumor Cells (CTCs) Prognostic Technologies Market Research Report with complete TOC at http://www.transparencymarketresearch.com/ctcs-prognostic-technologiesmarket.html
3.4 Porter’s Five Forces Analysis 3.4.1 Bargaining Power of Suppliers 3.4.2 Bargaining Power of Buyers 3.4.3 Threat of Substitutes 3.4.4 Threat of New Entrants 3.4.5 Competitive Rivalry 3.5 Event Impact Analysis (Historical Trends and Future Outlook), 2012 – 2020 3.6 Market Attractiveness Analysis of Global CTCs Prognostic Technologies Market, by Geography 3.7 Competitive Landscape 3.7.1 Global Market Share Analysis, by Key Players, Global CTCs Prognostic Technologies Market, 2013 (Value %)
Chapter 4 Global CTCs Prognostic Technologies Market, by Technology 4.1 Overview 4.2 Tumor Cell Enrichment 4.2.1 Global Tumor Cell Enrichment Market Revenue, 2012 – 2020 (USD Million) 4.2.2 Filtration 4.2.2.1 Global Tumor Cell Enrichment by Filtration Market Revenue, 2012 – 2020 (USD Million) 4.2.3 Centrifugation 4.2.3.1 Global Tumor Cell Enrichment by Centrifugation Market Revenue, 2012 – 2020 (USD Million) 4.2.4 Immunological and Immunomagnetic Methods 4.2.4.1 Global Tumor Cell Enrichment by Immunological and Immunomagnetic Methods Market Revenue, 2012 – 2020 (USD Million)
Browse Circulating Tumor Cells (CTCs) Prognostic Technologies Market Research Report with complete TOC at http://www.transparencymarketresearch.com/ctcs-prognostic-technologiesmarket.html
4.3 Tumor Cell Detection 4.3.1 Global Tumor Cell Detection Market Revenue, 2012 – 2020 (USD Million) 4.3.2 Molecular Methods 4.3.2.1 Global Tumor Cell Detection by Molecular Methods Market Revenue, 2012 – 2020 (USD Million) 4.3.3 Optical Methods 4.3.3.1 Global Tumor Cell Detection by Optical Methods Market Revenue, 2012 – 2020 (USD Million)
Chapter 5 Global CTCs Prognostic Technologies Market, by Applications 5.1 Overview 5.1.1 Global CTCs Prognostic Technologies Market Revenue, by Applications, 2012 – 2020 (USD Million) 5.2 Prostate Cancer 5.2.1 Global CTCs Application in Prostate Cancer Market Revenue, 2012 – 2020 (USD Million) 5.3 Breast Cancer 5.3.1 Global CTCs Application in Breast Cancer Market Revenue, 2012 – 2020 (USD Million) 5.4 Colorectal Cancer 5.4.1 Global CTCs Application in Colorectal Cancer Market Revenue, 2012 – 2020 (USD Million) 5.5 Others (Lung Cancer, Ovarian Cancer and Pancreatic Cancer) 5.5.1 Global CTCs Application in Other Cancer Types Market Revenue, 2012 – 2020 (USD Million)
Chapter 6 Global CTCs Prognostic Technologies Market, by Geography 6.1 Overview 6.1.1 Global CTCs Prognostic Technologies Market Revenue, by Geography, 2012 – 2020 (USD Million) 6.2 North America 6.2.1 North America CTCs Prognostic Technologies Market Revenue, 2012 – 2020 (USD Million) 6.3 Europe 6.3.1 Europe CTCs Prognostic Technologies Market Revenue, 2012 – 2020 (USD Million)
Browse Circulating Tumor Cells (CTCs) Prognostic Technologies Market Research Report with complete TOC at http://www.transparencymarketresearch.com/ctcs-prognostic-technologiesmarket.html
6.4 Asia-Pacific 6.4.1 Asia-Pacific CTCs Prognostic Technologies Market Revenue, 2012 – 2020 (USD Million) 6.5 Rest of the World (RoW) 6.5.1 RoW CTCs Prognostic Technologies Market Revenue, 2012 – 2020 (USD Million)
Chapter 7 Recommendations
Chapter 8 Company Profiles 8.1 AdnaGen GmbH 8.1.1 Company Overview 8.1.2 Financial Overview 8.1.3 Product Portfolio 8.1.4 Business Strategies 8.1.5 Recent Developments 8.2 Advanced Cell Diagnostics, Inc. 8.2.1 Company Overview 8.2.2 Financial Overview 8.2.3 Product Portfolio 8.2.4 Business Strategies 8.2.5 Recent Developments 8.3 AVIVA Biosciences Corporation
8.3.1 Company Overview 8.3.2 Financial Overview 8.3.3 Product Portfolio 8.3.4 Business Strategies 8.4 Celula, Inc. 8.4.1 Company Overview 8.4.2 Financial Overview 8.4.3 Product Portfolio 8.4.4 Business Strategies 8.5 Epic Sciences, Inc. 8.5.1 Company Overview 8.5.2 Financial Overview 8.5.3 Product Portfolio 8.5.4 Business Strategies 8.5.5 Recent Developments 8.6 Fluxion Biosciences, Inc. 8.6.1 Company Overview 8.6.2 Financial Overview 8.6.3 Product Portfolio 8.6.4 Business Strategies 8.6.5 Recent Developments 8.7 Rarecells USA, Inc. 8.7.1 Company Overview 8.7.2 Financial Overview 8.7.3 Product Portfolio
8.7.4 Business Strategies 8.8 Silicon Biosystems, S.p.A. 8.8.1 Company Overview 8.8.2 Financial Overview 8.8.3 Product Portfolio 8.8.4 Business Strategies 8.8.5 Recent Developments
Browse Circulating Tumor Cells (CTCs) Prognostic Technologies Market Research Report with complete TOC at http://www.transparencymarketresearch.com/ctcs-prognostic-technologiesmarket.html
8.9 Vitatex, Inc. 8.9.1 Company Overview 8.9.2 Financial Overview 8.9.3 Product Portfolio 8.9.4 Business Strategies 8.10 Veridex, LLC 8.10.1 Company Overview 8.10.2 Financial Overview 8.10.3 Product Portfolio 8.10.4 Business Strategies 8.10.5 Recent Developments
About Us
Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forwardlooking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact Transparency Market Research 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com/
Blog: http://tmrresearch.wordpress.com/